Akebia Therapeutics
AKBA
AKBA
165 hedge funds and large institutions have $190M invested in Akebia Therapeutics in 2025 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 63 increasing their positions, 48 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
28% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 32
44% less capital invested
Capital invested by funds: $338M → $190M (-$147M)
Holders
165
Holding in Top 10
–
Calls
$976K
Puts
$773K
Top Buyers
| 1 | +$6.15M | |
| 2 | +$3.86M | |
| 3 | +$3.34M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$3.1M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$1.97M |
Top Sellers
| 1 | -$7.89M | |
| 2 | -$6.69M | |
| 3 | -$6.46M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$5.81M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$5.23M |
